Medicine and Dentistry
Cohort Analysis
84%
Bloodstream Infection
83%
C Reactive Protein
30%
Pelvic Organ Prolapse
27%
Serum Albumin
21%
Urine Incontinence
21%
Enuresis
21%
Hysterectomy
16%
Albumin
15%
Stress Incontinence
15%
Neuro-Oncology
15%
Patient-Reported Outcome
15%
International Classification of Impairments, Disabilities and Handicaps
13%
Medical Record
12%
Intraurethral Drug Administration
12%
Infection
11%
Reoperation
11%
Postoperative Complication
11%
Children with Disabilities
10%
Patient Registry
10%
Patient with Crohn's Disease
10%
Rasch Analysis
10%
Comorbidity
9%
Disability Severity
9%
Malignant Neoplasm
8%
Spastic Diplegia
8%
Hearing Impairment
8%
Muscle Disease
8%
Spinal Dysraphism
8%
Intracranial Tumor
8%
Blood Culture
7%
Quality of Life
7%
Case-Control Study
7%
Biological Marker
7%
Incontinence
6%
Ganglioglioma
6%
Tumor Necrosis Factor
6%
Visual Impairment
5%
Spinal Muscular Atrophy
5%
Surgical Technique
5%
Uterine Prolapse
5%
Patient Characteristics
5%
Antibiotic Therapy
5%
Intensive Care Unit
5%
Pneumococcal Pneumonia
5%
Vancomycin
5%
Septic Shock
5%
Patient Referral
5%
Ulcerative Colitis
5%
Necrosis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
100%
Cohort Study
55%
C Reactive Protein
32%
Infection
24%
Serum Albumin
17%
Albumin
15%
Hypoalbuminemia
10%
Escherichia coli
10%
Stress Incontinence
10%
Ulcerative Colitis
10%
Mortality Rate
8%
Comorbidity
7%
Biological Marker
7%
Overall Survival
7%
Diseases
7%
Piperacillin Plus Tazobactam
6%
All Cause Mortality
6%
Tumor Necrosis Factor
6%
Streptococcus Pneumonia
5%
Incontinence
5%
Antibiotic Therapy
5%
Pelvic Organ Prolapse
5%
Cefuroxime
5%
Calgranulin
5%
Liver Disease
5%
Vancomycin-Resistant Enterococcus
5%
Vancomycin
5%
Capillary Leak Syndrome
5%
Enterococcus faecium
5%
Extended Spectrum Beta Lactamase
5%
Case-Control Study
5%
Glioblastoma
5%
Inflammatory Bowel Disease
5%
Uterine Cervix Cancer
5%
Clostridium Difficile Infection
5%
Acute Disease
5%
Recurrent Disease
5%
Chemotherapy
5%
Listeria Meningitis
5%
Postoperative Complication
5%
Immunotherapy
5%
Breech Presentation
5%
Prevalence
5%
Leukemia
5%
Infliximab
5%
Mixed Incontinence
5%
Crohn's Disease
5%
Urine Incontinence
5%
Hematologic Malignancy
5%
Enuresis
5%
Nursing and Health Professions
Cohort Analysis
17%
Bloodstream Infection
15%
Confidence Interval
10%
Biological Marker
6%
Intensive Care Unit
5%
Health Care Personnel
5%
Calgranulin
5%
Pelvic Organ Prolapse
5%
Ulcerative Colitis
5%
Patient with Crohn's Disease
5%
Inflammatory Bowel Disease
5%
Treatment Failure
5%
Stress Incontinence
5%
Endotracheal Tube
5%
Urine Incontinence
5%
Intraurethral Drug Administration
5%
Infliximab
5%
Leukemia
5%
Cesarean Section
5%
Case-Control Study
5%
Mixed Incontinence
5%
Disability Severity
5%
All Cause Mortality
5%
Patient-Reported Outcome
5%
Enuresis
5%
World Health Organization
5%
Clinical Outcome
5%
Treatment Outcome
5%
HIV Test
5%
